Equities
  • Price (USD)40.26
  • Today's Change-0.04 / -0.10%
  • Shares traded54.68k
  • 1 Year change+14.31%
  • Beta--
Data delayed at least 15 minutes, as of May 10 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AI:PAR since
announced
Transaction
value
Linde GMBH-Homecare Services For Respiratory TherapiesDeal completed07 Jul 202307 Jul 2023Deal completed20.38%--
Data delayed at least 15 minutes, as of May 10 2024 16:37 BST.

Institutional shareholders

0.07%Per cent of shares held by top holders
HolderShares% Held
MFS International (UK) Ltd.as of 31 Dec 2022613.67k0.02%
Fayez Sarofim & Co.as of 28 Mar 2024436.54k0.02%
Jarislowsky, Fraser Ltd.as of 28 Mar 2024262.20k0.01%
Eagle Global Advisors LLCas of 29 Dec 202398.42k0.00%
Domini Impact Investments LLCas of 31 Jan 202487.61k0.00%
Boston Common Asset Management LLCas of 31 Mar 202470.47k0.00%
Causeway Capital Management LLCas of 04 Apr 202465.98k0.00%
L&S Advisors, Inc.as of 31 Dec 202358.77k0.00%
Madison Asset Management LLCas of 31 Dec 202345.35k0.00%
RhumbLine Advisers LPas of 31 Dec 202340.03k0.00%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.